96948 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Growth factors; Growth regulators Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
METHODS AND MATERIALS FOR PROMOTING BONE GROWTH
#2Treatment of osteoarthritis and/or rheumatoid arthritis with pro-chondrogenic and/or chondrocyte protective factors
#3GENERATING DORSAL FOREGUT, AND ANTERIOR DOMAIN, ENDODERM CELLS
#4TARGETING ANABOLIC DRUGS FOR ACCELERATED FRACTURE REPAIR
#5Treatment of osteoarthritis and/or rheumatoid arthritis with pro-chondrogenic and/or chondrocyte protective factors
#6METHOD FOR REPAIRING HAIR CYCLE-RELATED GENES AND METHOD FOR TREATING HAIR CYCLE-RELATED DISEASES USING MIR-520D-5P
#7PERIOSTIN COMPOUNDS FOR THE TREATMENT OF HAEMATOLOGICAL COMPLICATIONS
#8COMPOSITION AND METHOD FOR DELIVERY OF BMP-2 AMPLIFIER/CO-ACTIVATOR FOR ENHANCEMENT OF OSTEOGENESIS
#9NON-INTEGRATING VIRAL DELIVERY SYSTEM AND METHODS RELATED THERETO
#10COMPOSITIONS AND METHODS FOR TARGETED THERAPEUTIC DELIVERY TO BONE
#11NON-INTEGRATING VIRAL DELIVERY SYSTEM AND METHODS RELATED THERETO
#12Pharmaceutical Composition for Promoting Osteoinduction and Angiogenesis
#13BMP9 OR AN AGONIST THEREOF AND ITS USES RELATED TO REDUCING METASTASIS OF CANCER
#14MESENCHYMAL STEM CELL LINE
#15TREATMENT OF BONE TISSUE TO INCREASE THE BIOAVAILABILITY OF GROWTH FACTORS
#16CHIMERIC PROTEINS FOR TARGETED DELIVERY OF GROWTH FACTORS TO THE GLOMERULUS
#17BINDING AGENTS
#18NOVEL HYBRID ACTRIIB LIGAND TRAP PROTEINS FOR TREATING MUSCLE WASTING DISEASES
#19Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
#20METHOD FOR EXPRESSING AND PURIFYING PROTEIN BY USING CSQ-TAG
#21mRNA INDUCED EXPRESSION OF BONE MORPHOGENIC PROTEIN AND RECEPTOR AND METHODS RELATED THERETO
#22BISPECIFIC BINDING AGENT-LIGAND FUSIONS FOR THE DEGRADATION OF TARGET PROTEINS
#23GDF11 VARIANTS AND USES THEREOF
#24GREMLIN-1 CRYSTAL STRUCTURE AND INHIBITORY ANTIBODY
#25THERAPEUTIC USE OF BONE MORPHOGENETIC PROTEINS
#26POLYPEPTIDES INCLUDING A BETA-TRICALCIUM PHOSPHATE-BINDING SEQUENCE AND USES THEREOF
#27HYDROGELS CONTAINING AFFIBODIES AND USES THEREOF
#28METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#29COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF
#30Targeting anabolic drugs for accelerated fracture repair
#31BONE MORPHOGENETIC PROTEIN-9 AND -10 VARIANTS WITH ENHANCED THERAPEUTIC EFFECT DUE TO REDUCED SIDE EFFECTS OF ECTOPIC OSSIFICATION AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
#32METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#33MUTATION COMPLEX INCLUDING GAIN-OF-FUNCTION MUTANT OF BMPR2 GENE, INDUCED PLURIPOTENT STEM CELLS AND MESENCHYMAL STEM CELLS DERIVED FROM MUTANT, AND USE THEREOF
#34METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#35METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#36METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#37METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#38METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#39Compositions and methods for targeted therapeutic delivery to bone
#40NOVEL GAIN-OF-FUNCTION MUTANT OF BMPR2 GENE AND USE THEREOF
#41THERAPEUTIC COMPOSITIONS COMPRISING GRAFT MATERIALS AND BETA-TCP BINDING PEPTIDES AND USES THEREOF
#42METHODS OF USING A TGF-beta KNOCKOUT CELL LINE AND COMPOSITIONS RESULTING THEREFROM
#43Polymer hydrogels for in vivo applications and methods for using and preparing same
#44STABILIZED PROTEOLYTICALLY ACTIVATED GROWTH DIFFERENTIATION FACTOR 11
#45Hybrid ActRIIB ligand trap proteins for treating muscle wasting diseases
#46Amino acid sequence of recombinant human bone morphogenetic protein-2
#47COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF
#48COMBINATION GRAFTS FOR TISSUE REPAIR OR REGENERATION APPLICATIONS
#49Methods of Treatment Using Encapsulated Cells
#50METHOD FOR EXPRESSING AND PURIFYING PROTEIN BY USING CSQ-TAG
#51GENERATING DORSAL FOREGUT, AND ANTERIOR DOMAIN, ENDODERM CELLS
#52Polypeptides including a beta-tricalcium phosphate-binding sequence and uses thereof
#53BMP-ALK3 ANTAGONISTS AND USES FOR PROMOTING BONE GROWTH
#54PERIOSTEAL SKELETAL STEM CELLS IN BONE REPAIR
#55Pharmaceutical compositions and methods targeting Wnt pathway proteins
#56ACTIVIN/BMP7 CHIMERAS: SUPER-ACTIVE SAB704 AND SAB715, AND THEIR RESPECTIVE NOGGINSENSITIZED VARIANTS, NAB704 AND NAB715; AND NAB204
#57Cyclic peptide from novel bone morphogenetic protein 2, preparation method therefor and application thereof
#58Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis
#59Osteogenic biomaterial
#60COMPOSITION FOR PREVENTING OR TREATING CARDIOFACIOCUTANEOUS SYNDROME
#61Methods and compositions for increasing red blood cells
#62Periostin compounds for the treatment of haematological complications
#63TARGETING ANABOLIC DRUGS FOR ACCELERATED FRACTURE REPAIR
#64Electrochemical attachment of phosphonic acids to metallic substrates and osteoconductive medical devices containing same
#65TARGETING ANABOLIC DRUGS FOR ACCELERATED FRACTURE REPAIR
#66GROWTH FACTOR CONCENTRATE AND METHOD OF MANUFACTURE THEREOF
#67Gremlin-1 crystal structure and inhibitory antibody
#68Antibodies specific for sulfation sites of Wnt pathway proteins
#69Variants of human BMP7 protein
#70GDF11 variants and uses thereof
#71MESENCHYMAL STEM CELLS OR STROMAL CELLS HARBORING MODIFIED RNAS ENCODING VEGF AND BMP POLYPEPTIDES
#72BMPRII POLYPEPTIDES AND USES THEREOF
#73Hybrid ActRIIB ligand trap proteins for treating muscle wasting diseases
#74Cancer stem cell-specific molecule
#75Sulfonated sclerostin, antibodies, epitopes and methods for identification and use therefor
#76GROWTH DIFFERENTIATION FACTOR (GDF) FOR TREATMENT OF DIASTOLIC HEART FAILURE
#77Cell-permeable bone morphogenetic protein (CPBMP) recombinant protein and use thereof
#78Polypeptides including a beta-tricalcium phosphate-binding sequence and uses thereof
#79Cell line which is knock out the bmp receptor genes and a method of producing target proteins using the same
#80Antibodies specific for sclerostin and methods for increasing bone mineralization
#81CD8 T cell subsets as a biomarker for predicting non-fusion after spinal fusion surgery
#82PEPTIDES HAVING OSTEOBLAST GROWTH-PROMOTING ACTIVITY AND USE THEREOF
#83BMP-2-binding peptide amphiphile nanofibers
#84Methods and compositions for increasing red blood cells
#85Electrochemical attachment of phosphonic acids to metallic substrates and osteoconductive medical devices containing same
#86COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE
#87Combination grafts for tissue repair or regeneration applications
#88Binding agents
#89POLYPEPTIDE OF RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2
#90STABILIZED PROTEOLYTICALLY ACTIVATED GROWTH DIFFERENTIATION FACTOR 11
#91Chimera of bone morphogenic protein 2 and the Müllerian-inhibiting substance type II receptor binding region of Müllerian-inhibiting substance
#92METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#93Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereof
#94Therapeutic use of bone morphogenetic proteins
#95Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereof
#96Recombinant polypeptides, compositions, and methods thereof
#97Gremlin-1 antibody
#98MESENCHYMAL STEM CELL-DERIVED EXTRACELLULAR VESICLES AND THEIR MEDICAL USE
#99Composition and method for delivery of BMP-2 amplifler/co-activator for enhancement of osteogenesis
#100Growth differentiation factor 15 (GDF-15) polypeptides
#101Polymer hydrogels for in vivo applications and methods for using and preparing same
#102Methods for treating bone loss using sclerostin peptides
#103GDF15 fusion proteins and uses thereof
#104Non-integrating viral delivery system and methods related thereto
#105Delivery of therapeutic agents by a collagen binding protein
#106RECOMBINANT NEL-LIKE (MELL) PROTEIN PRODUCTION
#107Composition for preventing or treating cardiofaciocutaneous syndrome
#108Designer osteogenic proteins
#109COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF
#110Implantable matrix having optimum ligand concentrations
#111BMP peptides and methods of use
#112COMPOSITION COMPRISING AN AB6 FAMILY DESIGNER LIGAND OF TGF-BETA SUPERFAMILY FOR TREATING LIVER DISEASE AND USE THEREOF
#113COMPOSITION COMPRISING AN AB6 FAMILY DESIGNER LIGAND OF TGF-BETA SUPERFAMILY FOR TREATING BONE AND CARTILAGE DISEASE AND USE THEREOF
#114Bone delivery conjugates and method of using same to target proteins to bone
#115Recombinant polypeptides and nucleic acid molecules, compositions, and methods of making and uses thereof
#116COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF
#117Isolation and Identification of Glycosaminoglycans
#118GROWTH DIFFERENTIATION FACTOR (GDF) FOR TREATMENT OF DIASTOLIC HEART FAILURE
#119BMP-ALK3 ANTAGONISTS AND USES FOR PROMOTING BONE GROWTH
#120COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF
#121Peptide having titanium-binding ability
#122Cell-permeable bone morphogenetic protein (CP-BMP) recombinant protein and use thereof
#123Compounds for inducing tissue formation and uses thereof
#124BMP-4 PEPTIDES AND METHOD OF USE
#125Methods and compositions for increasing red blood cells
#126BMP-7 PEPTIDES AND METHODS OF USE
#127Hybrid ActRIIB ligand trap proteins for treating muscle wasting diseases
#128Osteogenic proteins
#129Purification of bone morphogenetic proteins (BMPs)
#130Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis
#131ANTIBODIES SPECIFIC FOR SCLEROSTIN AND METHODS FOR INCREASING BONE MINERALIZATION
#132Designer osteogenic proteins
#133Cell-permeable (iCP)-SOCS3 recombinant protein and uses thereof
#134BMP-2 PEPTIDES AND METHODS OF USE
#135BMP peptides and methods of use
#136Method for preparing an induced osteogenesis formulation
#137GDF15 fusion proteins and uses thereof
#138Use of BMP4 for thymic regeneration
#139Osteogenic biomaterial
#140Growth differentiation factor 15 (GDF-15) polypeptides
#141Adeno-associated viral vectors for the gene therapy of metabolic diseases
#142POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN THE PROCESS OF BONE REMODELING
#143Therapeutic use of bone morphogenetic proteins
#144Delivery of therapeutic agents by a collagen binding protein
#145Sulfonated sclerostin, antibodies, epitopes and methods for identification and use therefor
#146RECOMBINANT NEL-LIKE (NELL) PROTEIN PRODUCTION
#147Cell-permeable (iCP)-SOCS3 recombinant protein and uses thereof
#148Composition and methods for tethering bioactive peptides to metal oxide surfaces
#149Polypeptide connected with an organic residue
#150PURIFICATION OF TGF-BETA SUPERFAMILY PROTEINS
#151THERAPEUTIC USE OF BONE MORPHOGENETIC PROTEINS
#152Methods and compositions comprising human recombinant growth and differentiation factor-5 (rhGDF-5)
#153Antibodies specific for sulfation sites of sclerostin
#154Methods for Diagnosing and Treating Iron Dysregulation
#155Positive modulator of bone morphogenic protein-2
#156Glycosaminoglycans
#157Peptides having osteoblast growth-promoting activity and use thereof
#158Pharmaceutical compositions targeting WNT pathway proteins
#159SPARC binding ScFvs
#160Growth differentiation factor (GDF) for treatment of diastolic heart failure
#161BIOACTIVE RECOMBINANT BMP-9 PROTEIN, MB109, EXPRESSED AND ISOLATED FROM BACTERIA
#162Designer osteogenic proteins
#163Compositions and methods for increasing bone mineralization
#164Cancer stem cell-specific molecule
#165SINGLE DOMAIN TDF-RELATED COMPOUNDS AND ANALOGS THEREOF
#166Method for producing natively folded proteins in a prokaryotic host
#167Polynucleotides and polypeptide sequences involved in the process of bone remodeling
#168Development of Protein-Based Biotherapeutics That Induced Osteogenesis for Bone Healing Therapy: Cell-Permeable BMP2 and BMP7 Recombinant Proteins (CP-BMP2 & CP-BMP7), Polynucleotides Encoding the Same and Pro-osteogenic Compositions Comprising the Same
#169Designer osteogenic proteins
#170Inhibitory polypeptides specific to WNT inhibitors
#171Preparing tooth-like structure using stem cell
#172Methods and compositions for bone formation
#173Use of fusion protein
#174Albumin fusion proteins
#175BMP-ALK3 antagonists and uses for promoting bone growth
#176Surgical applications for BMP binding protein
#177Host cell lines expressing recombinant GDF-5 protein
#178Bone morphogenic protein binding peptide
#179Albumin fusion proteins
#180Antibodies specific for sclerostin and methods for increasing bone mineralization
#181Bone matrix compositions and methods
#182Bone regeneration agent including gelatin
#183BMP Peptides & Methods of Use
#184Bone morphogenic protein binding peptide
#185Growth differentiation factor 11 (GDF-11) for treatment of diastolic heart failure
#186Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis
#187Cell-penetrating fusion protein for regenerating or proliferating stem cell
#188SPARC binding ScFcs
#189GDF-5 mutant for inducing cartilage formation
#190SPARC binding ScFcs
#191SPARC binding ScFvs
#192Recombinant NEL-like (NELL) protein production
#193Activated collagen scaffold materials and their special fused active restoration factors
#194Activated collagen scaffold materials and their special fused active restoration factors
#195Epitopes
#196Amphiphilic peptides and hydrogel matrices thereof for bone repair
#197Peptide bone forming peptide 4 for promoting osteogenesis or vascularization and use thereof
#198Surface-active collagen membrane by peptide
#199Compositions and Methods for Minimally-Invasive Systemic Delivery of Proteins Including TGF-Beta Superfamily Members
#200Polymer hydrogels for in vivo applications and methods for using and preparing same
#201Methods for Diagnosing and Treating Iron Dysregulation
#202Protein-binding peptide isolated from placenta growth factor
#203Cartilage oligomeric matrix protein (COMP)—growth factor complexes and uses thereof
#204Methods of making antibodies that bind polypeptides involved in the process of bone remodeling
#205Surgical applications for BMP binding protein
#206Methods for increasing red blood cell levels comprising administering BMP9
#207Cell-permeable peptide
#208BMP-4 peptides and methods of use
#209BMP-7 peptides and methods of use
#210BMP-7 Variants with Reduced Immunogenicity
#211BMP Mutants with Decreased Susceptibility to Noggin
#212Buffers for Controlling the pH of Bone Morphogenetic Proteins
#213Methods of decorating hydroxyapatite biomaterials with modular biologically active molecules
#214Compositions and methods for increasing bone mineralization
#215Polynucleotides encoding BMP-ALK3 antagonists
#216Bone morphogenic protein binding peptide
#217BMP-2 peptides and methods of use
#218Antibodies specific for sclerostin and methods for increasing bone mineralization
#219Antibodies specific for sclerostin and methods for increasing bone mineralization
#220Method for purifying bone morphogenetic protein
#221Methods and compositions for bone formation
#222SYSTEMS AND METHODS FOR PROTEIN PRODUCTION
#223Antibodies specific for sclerostin and methods for increasing bone mineralization
#224Oligopeptide improving differentiation of osteoblasts
#225PEPTIDE BFP4 FOR PROMOTING OSTEOGENESIS OR VASCULARIZATION AND USE THEREOF
#226Fibrous protein fusions and use thereof in the formation of advanced organic/inorganic composite materials
#227Method for inhibiting bone resorption
#228Antibodies that bind polypeptides involved in the process of bone remodeling
#229Modified and stabilized GDF propeptides and uses thereof
#230BMP10 propeptides and related methods
#231Method for producing natively folded proteins in a prokaryotic host
#232Bone regeneration agent comprising gelatin
#233Modified TGF-β superfamily protein
#234Expression System Of NELL Peptide
#235Sulfation of Wnt pathway proteins
#236Bone morphogenetic protein 2 (BMP2) variants with reduced BMP antagonist sensitivity
#237Designer osteogenic proteins
#238Albumin fusion proteins
#239SPARC binding peptides and uses thereof
#240SPARC binding ScFvs
#241PROCESS FOR PRODUCING RECOMBINANT PROTEIN USING NOVEL FUSION PARTNER
#242Antibodies that bind polypeptides involved in the process of bone remodeling
#243Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis
#244Epitopes
#245Antibodies specific for sulfated sclerostin
#246Sulfonated sclerostin, antibodies, epitopes and methods for identification and use therefor
#247POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN THE PROCESS OF BONE REMODELING
#248Fibrous protein fusions and use thereof in the formation of advanced organic/inorganic composite materials
#249PROTEOGLYCAN-BINDING PEPTIDES THAT MODULATE STEM CELL BEHAVIOR
#250RECOMBINANT NELL PROTEIN PRODUCTION
#251TECHNIQUE FOR REGULATING REGENRATION OF TISSUE OR FAULTY OR ABNORMAL PART IN ORGAN USING NELL-1
#252Buffers for Controlling the pH of Bone Morphogenetic Proteins
#253NELL-1 enhanced bone mineralization
#254Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
#255ANTIBODIES SPECIFIC FOR SCLEROSTIN AND METHODS FOR INCREASING BONE MINERALIZATION
#256Osteogenic synthetic peptides, pharmaceutical compositions comprising the same, and medium containing the same
#257Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
#258O-LINKED GLYCOSYLATION USING N-ACETYLGLUCOSAMINYL TRANSFERASES
#259Heparan sulphate which binds BMP2
#260Isolation and Identification of Glycosaminoglycans
#261Compositions and Methods for Increasing Bone Mineralization
#262Decorating hydroxyapatite biomaterials with modular biologically active molecules
#263GENETICALLY ENGINEERED CELLS WHICH EXPRESS BONE MORPHOGENIC PROTEINS
#264Polynucleotide encoding a sclerostin-binding antibody
#265Method for treating tumors and their metastases
#266PRODUCTION OF BONE MORPHOGENIC PROTEINS (BMPS) USING A NOVEL TISSUE CULTURE PLATFORM
#267Methods for Diagnosing and Treating Iron Dysregulation
#268Single domain TDF-related compounds and analogs thereof for use in treating a tissue differentiation factor related disorder
#269NELL-1 ENHANCED BONE MINERALIZATION
#270BMP Mutants with Decreased Susceptibility to Noggin
#271Q3 SPARC DELETION MUTANT AND USES THEREOF
#272Albumin fusion proteins
#273Modified and stabilized GDF propeptides and uses thereof
#274Single branch heparin-binding growth factor analogs
#275Polypeptides useful for appetite suppression
#276Finger-1 Peptide Analogs of the TGF-Beta Superfamily
#277GLYCOCONJUGATION OF POLYPEPTIDES USING OLIGOSACCHARYLTRANSFERASES
#278Osteogenic implants with combined implant materials and methods for same
#279Osteogenic implants with combined implant materials and methods for same
#280Osteogenic implants with combined implant materials and methods for same
#281BMP-ALK3 antagonists and uses for promoting bone growth
#282Plasmid encoding feline BMP-7
#283NELL peptide expression systems and bone formation activity of NELL peptide
#284Bone delivery conjugates and method of using same to target proteins to bone
#285Bone delivery conjugates and method of using same to target proteins to bone
#286Compositions and Methods for Minimally-Invasive Systemic Delivery of Proteins Including TGF-Beta Superfamily Members
#287Optimized DNA sequences encoding recombinant human bone morphogenetic protein-2 (rhBMP-2), preparation method and the uses thereof
#288Surgical applications for BMP binding protein
#289Compositions and methods for increasing bone mineralization
#290THERAPEUTIC AGENTS FOR ANGIOGENESIS-RELATED DISEASES COMPRISING CHONDROMODULIN-I AS ACTIVE INGREDIENT
#291Bone morphogenetic proteins containing a heparin binding site and osteogenic devices and pharmaceutical products containing thereof
#292NELL-1 peptides
#293ISOLATED MODIFIED HUMAN CHORIONIC GONADOTROPIN PROTEINS
#294Method of enhancing recombinant protein production
#295USE OF GDF-5 FOR THE IMPROVEMENT OR MAINTENANCE OF DERMAL APPEARANCE
#296Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue
#297Bone morphogenetic protein 3 and osteogenic devices and pharmaceutical products containing thereof
#298Osteogenic synthetic peptides, pharmaceutical compositions comprising the same, and medium containing the same
#299Amphiphilic peptides and hydrogel matrices thereof for bone repair
#300NOVEL BMP-12-RELATED PROTEINS AND METHODS OF THEIR MANUFACTURE